Anti-VEGF, anti-vascular endothelial growth factor; BCVA, best-corrected visual acuity; CFT, central foveal thickness; DR, diabetic retinopathy; EOFU, end of follow-up; ETDRS, Early Treatment Diabetic Retinopathy Study; IVF, intravitreal faricimab; N, naïve; S, switch; W52, week 52. The gene discussed is VEGFA; the disease is diabetic retinopathy.